Centre for Investigational New Product National Pharmaceutical Control Bureau, MOH.
IAS 2011_ Abstract # WEPDB0102 Sustained Efficacy and Tolerability of Raltegravir after 240 Weeks of Combination ART in Treatment- Naive HIV-1 Infected.
